Munafa Stock Market Course + Intraday & FNO calls 
Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Intellia Therapeutics (NTLA)
Technical Analysis Report for NASDAQ stock NTLA Intellia Therapeutics. Dated: 22 May 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics then click here. or read Experts views on Intellia Therapeutics or Forecast & share price targets of Intellia Therapeutics
Intellia Therapeutics Opened at 12.48 and Closed at: 12.60, which is 1.83% of previous session's close. It moved within a range of 12.35 and 12.89
The session was a Bullish session with an average volume of 2249037, which is -96.75% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
A Dead cross was found 2 days back on short term averages
A Golden cross was found 3 days back on short term averages
A Dead cross was found 4 days back on mid term averages
A Golden cross was found 9 days back on mid term averages
Support for tomorrow is 12.48 and resistance for tomorrow is 13.02
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 12.34, 12.07 resistance for tomorrow's hourly charts is 12.88, 13.15
10 Day SMA for Intellia Therapeutics (NTLA) is 13.13 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Intellia Therapeutics (NTLA) is 13.32 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Intellia Therapeutics (NTLA) is 13.57 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 13.08 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Intellia Therapeutics is 13.24 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Intellia Therapeutics is at 13.32 and 200 DMA is at 13.24, while 50 DMA and 100 DMA are at 13.57 and 13.08 respectively
Intellia Therapeutics (NTLA) moving average of 20 SMA is at 13.32 and 20 EMA is at 13.28
| Date | Closing Price | 20 SMA | 20 EMA |
| 22 Fri May | 12.60 | 13.32 | 13.28 |
| 21 Thu May | 12.37 | 13.34 | 13.35 |
| 20 Wed May | 12.26 | 13.4 | 13.45 |
| 19 Tue May | 11.93 | 13.58 | 13.57 |
| 18 Mon May | 12.69 | 13.81 | 13.74 |
| 15 Fri May | 13.66 | 13.95 | 13.85 |
Intellia Therapeutics (NTLA) moving average of 50 SMA is at 13.57 and 50 EMA is at 13.4
| Date | Closing Price | 50 SMA | 50 EMA |
| 22 Fri May | 12.60 | 13.57 | 13.4 |
| 21 Thu May | 12.37 | 13.57 | 13.43 |
| 20 Wed May | 12.26 | 13.59 | 13.47 |
| 19 Tue May | 11.93 | 13.61 | 13.52 |
| 18 Mon May | 12.69 | 13.65 | 13.59 |
| 15 Fri May | 13.66 | 13.66 | 13.63 |
Intellia Therapeutics (NTLA) moving average of 100 SMA is at 13.08 and 100 EMA is at 13.17
| Date | Closing Price | 100 SMA | 100 EMA |
| 22 Fri May | 12.60 | 13.08 | 13.17 |
| 21 Thu May | 12.37 | 13.05 | 13.18 |
| 20 Wed May | 12.26 | 13.01 | 13.2 |
| 19 Tue May | 11.93 | 12.99 | 13.22 |
| 18 Mon May | 12.69 | 12.96 | 13.25 |
| 15 Fri May | 13.66 | 12.93 | 13.26 |
Intellia Therapeutics (NTLA) moving average of 200 SMA is at 13.24 and 200 EMA is at 12.85
| Date | Closing Price | 200 SMA | 200 EMA |
| 22 Fri May | 12.60 | 13.24 | 12.85 |
| 21 Thu May | 12.37 | 13.23 | 12.85 |
| 20 Wed May | 12.26 | 13.22 | 12.85 |
| 19 Tue May | 11.93 | 13.22 | 12.86 |
| 18 Mon May | 12.69 | 13.22 | 12.87 |
| 15 Fri May | 13.66 | 13.21 | 12.87 |
Intellia Therapeutics has performed better than Trupanion Inc in short term. Holding Intellia Therapeutics could be a better choice for now!
Tonix Pharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Tonix Pharmaceuticals, about 5.18% more returns!
Tg Therapeutics has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Tg Therapeutics, about 16.96% more returns!
Intellia Therapeutics has performed better than Tenax Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Sutro Biopharma in short term. Holding Intellia Therapeutics could be a better choice for now!
Repligen Corporation has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Repligen Corporation, about 2.53% more returns!
Intellia Therapeutics has performed better than Ultragenyx Pharmaceutical in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Ovid Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Orthofix Medical in short term. Holding Intellia Therapeutics could be a better choice for now!
Merit Medical has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Merit Medical, about 0.7% more returns!
Intellia Therapeutics has performed better than Acadia Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!
Amarin Corporation has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Amarin Corporation, about 7.92% more returns!
Intellia Therapeutics has performed better than Anaptysbio Inc in short term. Holding Intellia Therapeutics could be a better choice for now!
Ascendis Pharma has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Ascendis Pharma, about 15.79% more returns!
Biogen Inc has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Biogen Inc, about 10.21% more returns!
Collegium Pharmaceutical has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Collegium Pharmaceutical, about 8.3% more returns!
Intellia Therapeutics has performed better than Dbv Technologies in short term. Holding Intellia Therapeutics could be a better choice for now!
Fortress Biotech has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Fortress Biotech, about 20.28% more returns!
Intellia Therapeutics has performed better than Harrow Health in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics Technical analysis of indicators
Price action analysis of Intellia Therapeutics (NTLA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Intellia Therapeutics in short term and the sell signal is strong.
Intellia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Intellia Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Intellia Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 13.2 and Intellia Therapeutics NTLA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics NTLA stock. Volume based technical analysis of Intellia Therapeutics NTLA stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NTLA Experts View which covers a lot of information including buying and selling signals
NTLA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Intellia Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
